How dependent is India on Drug-Eluting Cardiac Stents imports?

India imports $0.40 bn, mostly from USA. Its Critical Manufacturing Dependency Index is 69.75/100 (High), with a localisation potential of 49.75.

Drug-Eluting Cardiac Stents

High dependencyBuild-nowMedical DevicesReasoned estimateHS 9021.10

$0.40 bnAnnual import

25%Indian capability

3,525Supplier concentration (HHI)

₹800 crTo localise

Why India imports it. Boston Scientific, Medtronic, Abbott dominate; Sahajanand Medical has Indian DES.

Why it matters. Cardiovascular disease burden in India.

Can India localise it? Yes - 3-5 years.

Where it comes from. USA (45%), Ireland (30%), Germany (20%).

Scorecard

CMDI 69.75Dependency

LPI 49.75Localisation potential

IAI 59.75Investment attractiveness

SRI 62.5Supply risk

SCI 56.75Supply-chain complexity

TRI 41.5Technology readiness

IMI 67Industrial multiplier

NSRI 58.25National-security relevance

EPI 59.5Export potential

ICGI 66.75Capability gap

Who makes it

Sahajanand Medical Technologies

Boston ScientificMedtronicAbbott

On the ground

Sahajanand Medical Stent ManufacturingSahajanand Medical Technologies · gujarat · operational · ₹350 cr

Intelligence

Sources

Confidence: Reasoned estimate. Reasoned estimate. Part of Techadyant Labs' Critical Manufacturing Dependencies (Edition I).